Avadel Pharmaceuticals (AVDL) Receivables - Net: 2009-2019
Historic Receivables - Net for Avadel Pharmaceuticals (AVDL) over the last 11 years, with Dec 2019 value amounting to $8.3 million.
- Avadel Pharmaceuticals' Receivables - Net fell 44.04% to $5.7 million in Q2 2020 from the same period last year, while for Jun 2020 it was $5.7 million, marking a year-over-year decrease of 44.04%. This contributed to the annual value of $8.3 million for FY2019, which is 26.91% down from last year.
- Per Avadel Pharmaceuticals' latest filing, its Receivables - Net stood at $8.3 million for FY2019, which was down 26.91% from $11.3 million recorded in FY2018.
- Over the past 5 years, Avadel Pharmaceuticals' Receivables - Net peaked at $17.8 million during FY2016, and registered a low of $7.5 million during FY2015.
- Moreover, its 3-year median value for Receivables - Net was $11.3 million (2018), whereas its average is $11.5 million.
- As far as peak fluctuations go, Avadel Pharmaceuticals' Receivables - Net spiked by 345.92% in 2015, and later decreased by 26.91% in 2019.
- Avadel Pharmaceuticals' Receivables - Net (Yearly) stood at $7.5 million in 2015, then soared by 138.27% to $17.8 million in 2016, then dropped by 17.12% to $14.8 million in 2017, then dropped by 23.37% to $11.3 million in 2018, then decreased by 26.91% to $8.3 million in 2019.